M&T Bank Corp Biomarin Pharmaceutical Inc Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, M&T Bank Corp holds 6,469 shares of BMRN stock, worth $435,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,469

Previous 6,469 -0.0%

Holding current value

$435,881

Previous $454,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$69.02 - $93.84 $6,763 - $9,196	98 Added 1.54%	6,469 $454,000
Q2 2024 Jul 31, 2024	BUY	$74.43 - $92.22 $8,782 - $10,881	118 Added 1.89%	6,371 $524,000
Q1 2024 May 07, 2024	SELL	$83.81 - $99.0 $61,348 - $72,468	-732 Reduced 10.48%	6,253 $546,000
Q4 2023 Feb 06, 2024	SELL	$76.22 - $98.51 $7,164 - $9,259	-94 Reduced 1.33%	6,985 $673,000
Q3 2023 Nov 02, 2023	BUY	$85.07 - $94.48 $1,105 - $1,228	13 Added 0.18%	7,079 $626,000
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $5,027 - $5,817	58 Added 0.83%	7,066 $612,000
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $35,710 - $47,728	407 Added 6.17%	7,008 $681,000
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $69,437 - $93,204	858 Added 13.16%	7,376 $763,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $62,720 - $84,188	-775 Reduced 10.51%	6,601 $683,000
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $20,211 - $23,847	-246 Reduced 3.64%	6,518 $549,000
Q2 2022 Aug 05, 2022	BUY	$71.48 - $86.85 $3,359 - $4,081	47 Added 0.7%	6,764 $546,000
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $120,630 - $150,528	1,624 Added 31.89%	6,717 $517,000
Q4 2021 Feb 07, 2022	SELL	$71.72 - $91.47 $137,630 - $175,530	-1,919 Reduced 27.37%	5,093 $450,000
Q3 2021 Oct 28, 2021	SELL	$74.77 - $85.47 $7,103 - $8,119	-95 Reduced 1.34%	7,012 $542,000
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $3,851 - $4,324	-51 Reduced 0.71%	7,107 $593,000
Q1 2021 May 06, 2021	SELL	$74.73 - $90.69 $166,050 - $201,513	-2,222 Reduced 23.69%	7,158 $540,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $14,013 - $17,408	193 Added 2.1%	9,380 $822,000
Q3 2020 Nov 06, 2020	BUY	$71.87 - $131.03 $122,466 - $223,275	1,704 Added 22.77%	9,187 $700,000
Q2 2020 Jul 29, 2020	SELL	$79.55 - $124.22 $26,887 - $41,986	-338 Reduced 4.32%	7,483 $923,000
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $12,204 - $16,561	171 Added 2.24%	7,821 $659,000
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $13,175 - $17,705	205 Added 2.75%	7,650 $648,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $75,825 - $95,748	-1,125 Reduced 13.13%	7,445 $502,000
Q2 2019 Aug 12, 2019	SELL	$80.35 - $93.9 $38,487 - $44,978	-479 Reduced 5.29%	8,570 $735,000
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $361,218 - $423,079	-4,290 Reduced 32.16%	9,049 $803,000
Q4 2018 Feb 01, 2019	SELL	$80.14 - $106.07 $14,906 - $19,729	-186 Reduced 1.38%	13,339 $1.14 Million
Q3 2018 Nov 09, 2018	BUY	$93.92 - $105.72 $21,319 - $23,998	227 Added 1.71%	13,525 $1.31 Million
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $54,803 - $71,400	721 Added 5.73%	13,298 $1.25 Million
Q1 2018 May 04, 2018	BUY	$77.67 - $92.63 $13,669 - $16,302	176 Added 1.42%	12,577 $1.02 Million
Q4 2017 Feb 06, 2018	SELL	$80.76 - $95.13 $95,216 - $112,158	-1,179 Reduced 8.68%	12,401 $1.11 Million
Q3 2017 Nov 13, 2017	SELL	$80.6 - $94.95 $107,359 - $126,473	-1,332 Reduced 8.93%	13,580 $1.26 Million
Q2 2017 Aug 11, 2017	BUY	N/A	14,912	14,912 $1.36 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account